AI isn’t close to curing cancer. This startup says it knows what it will take.

While current models excel at predictive analysis, true breakthroughs in oncology require high-fidelity biological datasets that go beyond existing medical literature. By focusing on data architecture over mere algorithmic complexity, this startup addresses the fundamental bottleneck hindering precision medicine.